NRX PHARMACEUTICALS INC's ticker is NRXPW and the CUSIP is 629444118. A total of 5 filers reported holding NRX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $1,999 | +45.7% | 15,409 | -10.0% | 0.00% | – |
Q3 2023 | $1,372 | -68.0% | 17,129 | 0.0% | 0.00% | -100.0% |
Q2 2023 | $4,282 | +38.9% | 17,129 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $3,083 | -28.0% | 17,129 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $4,284 | -14.3% | 17,129 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $5,000 | +150.0% | 17,129 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | -86.7% | 17,129 | 0.0% | 0.00% | -100.0% |
Q1 2022 | $15,000 | -68.8% | 17,129 | -34.2% | 0.00% | -66.7% |
Q4 2021 | $48,000 | -65.5% | 26,048 | -10.3% | 0.01% | -72.7% |
Q3 2021 | $139,000 | -4.1% | 29,048 | -28.6% | 0.02% | -8.3% |
Q2 2021 | $145,000 | – | 40,700 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Yakira Capital Management, Inc. | 15,409 | $1,999 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
WOLVERINE ASSET MANAGEMENT LLC | 7,657 | $993 | 0.00% |
Tower Research Capital LLC (TRC) | 15 | $2 | 0.00% |